Key result
Women with atrial fibrillation had a lower risk of ischemic stroke, myocardial infarction, and cardiovascular death compared to men.
Why the study?
Data remain controversial on whether women with atrial fibrillation have a higher risk of adverse events than men during long-term follow-up.
Does female sex alter the risk of adverse cardiovascular events in patients with atrial fibrillation compared to male sex?
Cohort (n=3,894)
Yes
Does female sex alter the risk of adverse cardiovascular events in patients with atrial fibrillation compared to male sex?
Answers are grounded in this paper and cite their sources.
In patients with established atrial fibrillation, women have a lower risk of cardiovascular and non-cardiovascular death compared to men, with no significant differences in stroke, myocardial infarction, or bleeding.
OBJECTIVE: To assess whether women with atrial fibrillation (AF) have a higher risk of adverse events than men during long-term follow-up since controversial data have been published. METHODS: In the context of two very similar observational multicentre cohort studies, we prospectively followed 3894 patients (28% women) with previously documented AF for a median of 4.02 (3.00-5.83) years. The primary outcome was a composite of ischaemic stroke, myocardial infarction and cardiovascular death. Secondary outcomes included the individual components of the composite outcome, hospitalisation for heart failure, major and clinically relevant non-major bleeding, stroke or systemic embolism and non-cardiovascular death. RESULTS: Mean age was 73.1 years in women vs 70.8 years in men. The incidence of the primary endpoint in women versus men was 2.46 vs 3.24 per 100 patient-years, respectively (adjusted HR (aHR) 0.74, 95% CI 0.58 to 0.94; p=0.01). Women died less frequently from cardiovascular (aHR 0.57, 95% CI 0.41 to 0.78; p<0.001) and non-cardiovascular causes (aHR 0.68, 95% CI 0.47 to 0.98; p=0.04). There were no significant sex-specific differences in stroke (incidence 1.05 vs 1.00; aHR 1.02, 95% CI 0.70 to 1.49, p=0.93), myocardial infarction (incidence 0.67 vs 0.72; aHR 0.98, 95% CI 0.61 to 1.57, p=0.94), major and clinically relevant non-major bleeding (incidence 4.51 vs 4.34; aHR 0.95, 95% CI 0.79 to 1.15, p=0.63) or heart failure hospitalisation (incidence 3.28 vs 3.07; aHR 1.06, 95% CI 0.85 to 1.32, p=0.60). CONCLUSION: In this large study of patients with established AF, women had a lower risk of death than men, but there were no sex-specific differences in other adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Doerpfeld et al. (2022) conducted a cohort in Atrial fibrillation (n=3,894). Female sex vs. Male sex was evaluated on Composite of ischaemic stroke, myocardial infarction and cardiovascular death (aHR 0.74, 95% CI 0.58 to 0.94, p=0.01). Women with atrial fibrillation had a lower risk of ischemic stroke, myocardial infarction, and cardiovascular death compared to men.
Synapse has enriched 10 related papers. Consider them for comparative context: